Halper Sadeh LLC Launches Investigation into Major Companies for Shareholder Rights Violations Halper Sadeh LLC is probing Barnes Group, Poseida Therapeutics, Adams Resources, and Profire Energy for possible federal law violations impacting shareholders.

Halper Sadeh LLC Launches Investigation into Major Companies for Shareholder Rights Violations #United_States #New_York #Poseida_Therapeutics #Profire_Energy #Barnes_Group

Shareholders of PFIE, PSTX, ARCH, and B Urged to Take Action on Mergers Monteverde & Associates encourages shareholders of Profire Energy, Poseida Therapeutics, Arch Resources, and Barnes Group to act promptly regarding upcoming merger agreements.

Shareholders of PFIE, PSTX, ARCH, and B Urged to Take Action on Mergers #United_States #New_York #Monteverde_Associates #Poseida_Therapeutics #Profire_Energy

Poseida Therapeutics Presents Encouraging Phase 1 Results for P-BCMA-ALLO1 at ASH 2024 At the 66th ASH Annual Meeting, Poseida Therapeutics shared promising interim Phase 1 data for P-BCMA-ALLO1, indicating strong patient responses and cellular persistence.

Poseida Therapeutics Presents Encouraging Phase 1 Results for P-BCMA-ALLO1 at ASH 2024 #United_States #San_Diego #Poseida_Therapeutics #CAR-T_therapy #P-BCMA-ALLO1

Monteverde & Associates Investigates Poseida Therapeutics Merger Proposal with Roche Holdings Monteverde & Associates PC investigates the proposed merger between Poseida Therapeutics and Roche Holdings. Shareholders may need to take action.

Monteverde & Associates Investigates Poseida Therapeutics Merger Proposal with Roche Holdings #United_States #New_York #Monteverde_Associates #Poseida_Therapeutics #Roche_Holdings

Halper Sadeh LLC Launches Investigation into Potential Shareholder Rights Violations Halper Sadeh LLC is investigating several companies for possible breaches of federal securities law affecting shareholder rights. This article explores the implications.

Halper Sadeh LLC Launches Investigation into Potential Shareholder Rights Violations #United_States #New_York #Poseida_Therapeutics #Innovid_Corp #Atlantic_Union_Bankshares

Poseida Therapeutics Announces Acquisition by Roche Holdings to Enhance CAR-T Therapy Pipeline Poseida Therapeutics has entered into a merger agreement to be acquired by Roche Holdings for up to $13.00 per share, enhancing CAR-T therapy R&D.

Poseida Therapeutics Announces Acquisition by Roche Holdings to Enhance CAR-T Therapy Pipeline #United_States #San_Diego #Poseida_Therapeutics #Roche_Holdings #CAR-T_therapy